We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 13, 2020

Hypofractionated Whole Breast Radiotherapy With Concurrent Anti-HER2 Therapy

Clinical Breast Cancer


Additional Info

Clinical Breast Cancer
Utilization of Hypofractionated Whole Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy
Clin. Breast Cancer 2020 Jun 29;[EPub Ahead of Print], M Sayan, I Vergalasova, S Jhawar, et al

Further Reading